Recent progress in the application of plant-based colloidal drug delivery systems in the pharmaceutical sciences
Copyright © 2022 Elsevier B.V. All rights reserved..
The potential for utilizing plant-derived components, such as plant proteins, polysaccharides, lipids, and phospholipids, to create targeted drug delivery systems has been demonstrated in recent years. These colloidal delivery systems can encapsulate, protect, and release pharmaceuticals, vitamins, and nutraceuticals, thereby improving their bioavailability and efficacy. Moreover, they have the potential to reduce the side effects associated with some conventional drug formulations, while still achieving controlled or targeted delivery of pharmaceutical agents by various administration routes, including oral, nasal, dermal and inhalation. The pharmacokinetic and pharmacodynamic profiles of drugs can be modulated by altering the composition, dimensions, and structure of drug formulations created using plant-based colloidal delivery systems. The utilization of plant-derived ingredients may also reduce the environmental impact and improve the sustainability of drug formulations. Initially, we provide an overview of the general characteristics and requirements of drug delivery systems. The opportunities and challenges of using plant-derived components to fabricate colloidal particles for drug delivery applications is then discussed. Finally, potential clinical applications of plant-based delivery drug systems are reviewed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:307 |
|---|---|
| Enthalten in: |
Advances in colloid and interface science - 307(2022) vom: 01. Sept., Seite 102734 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Mohammadi, Keyhan [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 30.08.2022 Date Revised 06.09.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.cis.2022.102734 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM344373681 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM344373681 | ||
| 003 | DE-627 | ||
| 005 | 20231226022623.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cis.2022.102734 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1147.xml |
| 035 | |a (DE-627)NLM344373681 | ||
| 035 | |a (NLM)35917768 | ||
| 035 | |a (PII)S0001-8686(22)00136-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Mohammadi, Keyhan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Recent progress in the application of plant-based colloidal drug delivery systems in the pharmaceutical sciences |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.08.2022 | ||
| 500 | |a Date Revised 06.09.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2022 Elsevier B.V. All rights reserved. | ||
| 520 | |a The potential for utilizing plant-derived components, such as plant proteins, polysaccharides, lipids, and phospholipids, to create targeted drug delivery systems has been demonstrated in recent years. These colloidal delivery systems can encapsulate, protect, and release pharmaceuticals, vitamins, and nutraceuticals, thereby improving their bioavailability and efficacy. Moreover, they have the potential to reduce the side effects associated with some conventional drug formulations, while still achieving controlled or targeted delivery of pharmaceutical agents by various administration routes, including oral, nasal, dermal and inhalation. The pharmacokinetic and pharmacodynamic profiles of drugs can be modulated by altering the composition, dimensions, and structure of drug formulations created using plant-based colloidal delivery systems. The utilization of plant-derived ingredients may also reduce the environmental impact and improve the sustainability of drug formulations. Initially, we provide an overview of the general characteristics and requirements of drug delivery systems. The opportunities and challenges of using plant-derived components to fabricate colloidal particles for drug delivery applications is then discussed. Finally, potential clinical applications of plant-based delivery drug systems are reviewed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Controlled release | |
| 650 | 4 | |a Drug-therapy | |
| 650 | 4 | |a Natural-based particles | |
| 650 | 4 | |a Plant ingredients | |
| 650 | 4 | |a Sustainability | |
| 650 | 4 | |a Targeted drug-delivery systems | |
| 650 | 7 | |a Delayed-Action Preparations |2 NLM | |
| 650 | 7 | |a Drug Carriers |2 NLM | |
| 650 | 7 | |a Pharmaceutical Preparations |2 NLM | |
| 700 | 1 | |a Sani, Mahmood Alizadeh |e verfasserin |4 aut | |
| 700 | 1 | |a Azizi-Lalabadi, Maryam |e verfasserin |4 aut | |
| 700 | 1 | |a McClements, David Julian |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Advances in colloid and interface science |d 1996 |g 307(2022) vom: 01. Sept., Seite 102734 |w (DE-627)NLM014002183 |x 1873-3727 |7 nnns |
| 773 | 1 | 8 | |g volume:307 |g year:2022 |g day:01 |g month:09 |g pages:102734 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.cis.2022.102734 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 307 |j 2022 |b 01 |c 09 |h 102734 | ||